Equities

Glucose Health Inc

GLUC:PKC

Glucose Health Inc

Actions
  • Price (USD)0.17
  • Today's Change-0.04 / -19.05%
  • Shares traded17.46k
  • 1 Year change-25.27%
  • Beta3.5112
Data delayed at least 15 minutes, as of Sep 20 2024 19:20 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Glucose Health Inc grew revenues 98.39% from 480.71k to 953.68k while net income improved from a loss of 477.68k to a smaller loss of 338.90k.
Gross margin47.19%
Net profit margin-31.99%
Operating margin-31.99%
Return on assets--
Return on equity--
Return on investment--
More ▼

Cash flow in USDView more

In 2021, Glucose Health Inc increased its cash reserves by 988.07%, or 683.25k. Cash Flow from Financing totalled 755.99k or 79.27% of revenues. In addition the company used 72.74k for operations while cash from investing was breakeven.
Cash flow per share--
Price/Cash flow per share--
Book value per share0.0561
Tangible book value per share0.0559
More ▼

Balance sheet in USDView more

Glucose Health Inc appears to have little financial risk as the company holds a substantial amount of cash on its books with little or no debt.
Current ratio534.86
Quick ratio313.11
Total debt/total equity0.00
Total debt/total capital0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.